4.3 Article

IgM to S-nitrosylated protein is found intrathecally in relapsing-remitting multiple sclerosis

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 256, Issue 1-2, Pages 77-83

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2012.12.011

Keywords

Multiple sclerosis; Intrathecal synthesis; IgM; S-nitrosocysteine; S-nitrosylation; Biomarker

Funding

  1. National Multiple Sclerosis Society, USA [PP1366]
  2. Norwegian University of Science and Technology

Ask authors/readers for more resources

This study has established the presence of IgM against S-nitrosylated proteins in cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients using S-nitrosocysteine epitope (anti-SNOcys) as previously shown in serum. Anti-SNOcys IgM increased significantly in CSF during relapsing-remitting MS compared to milder neurological conditions. Evidence from albumin, IgG and IgM suggest that the production of anti-SNOcys IgM is intrathecal rather than the result of ingress from serum. Two correlations during relapse: between CSF level of anti-SNOcys IgM and time elapsed since relapse onset; and between CSF and serum anti-SNOcys IgM levels, suggest that this antibody may have potential as a biomarker. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Cut-off evaluation of intrathecal oligoclonal bands of IgM in relapsing-remitting multiple sclerosis; a retrospective study

Charlotte Hvaring, Noor Alawad, Oyvind Salvesen, Harald Hovdal, Linda R. White, Anne I. Boullerne

Summary: This pilot study examines the role of IgM bands in the cerebrospinal fluid of multiple sclerosis patients, and the results suggest that these bands may have prognostic potential for relapsing-remitting multiple sclerosis. However, further larger studies are needed to validate these findings.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)

No Data Available